COOPERATION AGREEMENTCooperation Agreement • June 25th, 2020 • Theravance Biopharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 25th, 2020 Company Industry JurisdictionThis COOPERATION AGREEMENT (this “Agreement”) is entered into as of June 22, 2020, by and among Theravance BIOPHARMA, Inc. (the “Company”), GlaxoSmithKline plc (“GSK”) and GSK FINANCE (NO.3) PLC (the “Issuer”).
COOPERATION AGREEMENTCooperation Agreement • June 22nd, 2020 • Glaxosmithkline PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 22nd, 2020 Company Industry JurisdictionThis COOPERATION AGREEMENT (this “Agreement”) is entered into as of June 22, 2020, by and among Theravance BIOPHARMA, Inc. (the “Company”), GlaxoSmithKline plc (“GSK”) and GSK FINANCE (NO.3) PLC (the “Issuer”).